NCT05681481: An ongoing trial by argenx
This trial is ongoing. It must report results 3 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05681481 |
|---|---|
| Title | An Open-label Extension Study of ARGX-113-2009 to Evaluate the Long Term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 22, 2023 |
| Completion date | March 20, 2025 |
| Required reporting date | March 20, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |